ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0294

Dysregulation of the Renal Autonomous Innervation with Elevated Blood Pressure Due to Lack of Sodium Nav1.8 Channels

Session Information

Category: Hypertension and CVD

  • 1601 Hypertension and CVD: Basic

Authors

  • Hutter, Eva, Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Ditting, Tilmann, Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Hilgers, Karl F., Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Morath, Christian, Paracelsus Medizinische Privatuniversitat - Nurnberg, Nuremberg, BY, Germany
  • Schmieder, Roland E., Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Schiffer, Mario, Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Amann, Kerstin U., Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Veelken, Roland, Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
  • Rodionova, Kristina, Friedrich-Alexander-Universitat Erlangen-Nurnberg Medizinische Fakultat, Erlangen, BY, Germany
Background

Reduced activity of cultivated neurons with renal axons is associated with absent voltage-gated sodium Nav1.8 channels. Now we tested the hypothesis that this monogenetic deletion is accompanied by directly recorded increased renal sympathetic nerve activity (RSNA) and decreased sympathoinhibitory afferent renal nerve activity (ARNA) in Nav 1.8 KO mice in vivo.

Methods

In Nav1.8 KO mice and C57BL6 (28th week of age; n=4), we analyzed directly recorded renal sympathetic nerve activity (RSNA assessing burst amplitude & burst duration) and afferent renal nerve activity (ARNA; after ganglionic blockade). Furthermore, we measured blood pressure (BP), heart rate (HR), eventually assessed transdermally the glomerular filtration rate (GFR) and signs of renal fibrosis.

Results

As a sign of activity, burst frequency of RSNA was higher in Nav 1.8 KO mice as compared to controls: during a period of 400 sec, we counted a median burst activity in Nav 1.8 mice of 6870 bursts (25%: 5532.5; 75%:7665.0) versus in controls 4879.5 (25%: 4628.000;75%; 5967.000). The Mann-Whitney Rank Sum Test suggested a statistically significant difference between Nav1.8 and controls (P=0.002). The test for normality was passed (P = 0.198). Burst were significantly broader in Nav 1.8 mice as in controls. Median spike production of ARNA was significantly altered in Nav 1.8 KO mice (170 spikes/min) as compared to controls (1384 spikes/min). Blood pressure of Nav1.8 KO mice was significantly elevated compared to controls. Nav1.8 KO mice showed signs of renal fibrosis (increased Collagen Type 1 and 4, CD 68 and CD 3 cells). However, GFR was yet not decreased in Nav1.8 KO mice at 28th week of age as assessed transdermally.

Conclusion

The hypertensive Nav1.8 KO mouse model suggests for the first time one conclusive mechanism to explain neurogenically induced elevated blood pressure by the renal autonomous innervation. These findings will help to better understand renal nerve ablation and probably open the path to new antihypertensive strategies.

Funding

  • Other NIH Support

Digital Object Identifier (DOI)